Apotex to Distribute Important Transdermal System for Management of Chronic
Pain in the U.S. Market
WESTON, FL,
The Fentanyl Transdermal System, developed by Hisamitsu, is manufactured at the company's state of the art Carlsbad, California facility. The total Fentanyl patch market in the U.S. represents approximately
Apotex Corp has a strong sales and marketing group that has positioned the company in the top tier of generic pharmaceutical organizations in the U.S. market. "We are excited to include this important, quality product in our portfolio and to be able to offer it to our valued healthcare partners" stated
Apotex has over 6,000 employees worldwide and produces over 300 medicines in 4,000 dosages, in 21 facilities in
For further information: For further information: US: Steve Giuli, Director, Government Affairs, Apotex Corp, Tel: (954) 384-8007, Ext. 3984, e-mail: [email protected]; Canada: Elie Betito, Director, Public & Government Affairs, Apotex Inc., Tel: (416) 749-9300, Ext. 7366, email: [email protected]
Share this article